These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1683023)

  • 1. Cardiac responses to drugs at the extremes of age.
    Papp JG
    Therapie; 1991; 46(4):283-91. PubMed ID: 1683023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS; Illsley SS
    Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of time- and frequency- domain-based measures of heart rate variability in individuals taking antiarrhythmics, beta blockers, calcium channel blockers, and/or antihypertensive drugs after sudden cardiac arrest.
    Cowan MJ; Pike K; Burr RL; Cain KC; Narayanan SB
    J Electrocardiol; 1993; 26 Suppl():1-13. PubMed ID: 7910623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs.
    Adams HR
    J Am Vet Med Assoc; 1986 Sep; 189(5):525-32. PubMed ID: 2875984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure.
    Packer M
    Circulation; 1990 Aug; 82(2 Suppl):I77-88. PubMed ID: 1973643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic receptor--effector coupling during post-natal development.
    Robinson RB
    Cardiovasc Res; 1996 Feb; 31 Spec No():E68-76. PubMed ID: 8681348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related alterations in the cardiovascular response to adrenergic mediated stress.
    Lakatta EG
    Fed Proc; 1980 Dec; 39(14):3173-7. PubMed ID: 6108242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenergic betareceptors and cardiac insufficiency].
    Weber S; Cabanes L; Guérin F
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1957-61. PubMed ID: 1980187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unwanted drug interaction between anti-arrhythmic drugs and drugs used for heart failure].
    Jaźwińska-Tarnawska E; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):614-7. PubMed ID: 11126988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug therapy: new drugs and changing concepts.
    Reiser HJ; Sullivan ME
    Fed Proc; 1986 Jul; 45(8):2206-12. PubMed ID: 2873062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.